33.50
price up icon0.30%   0.10
after-market Dopo l'orario di chiusura: 33.80 0.30 +0.90%
loading
Precedente Chiudi:
$33.40
Aprire:
$31.5
Volume 24 ore:
7.80M
Relative Volume:
2.18
Capitalizzazione di mercato:
$3.76B
Reddito:
-
Utile/perdita netta:
$-99.15M
Rapporto P/E:
-36.02
EPS:
-0.93
Flusso di cassa netto:
$-74.25M
1 W Prestazione:
+4.46%
1M Prestazione:
+24.30%
6M Prestazione:
-2.90%
1 anno Prestazione:
-33.54%
Intervallo 1D:
Value
$31.22
$34.67
Intervallo di 1 settimana:
Value
$31.22
$34.67
Portata 52W:
Value
$18.92
$81.73

Viking Therapeutics Inc Stock (VKTX) Company Profile

Name
Nome
Viking Therapeutics Inc
Name
Telefono
858-704-4660
Name
Indirizzo
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Name
Dipendente
46
Name
Cinguettio
@viking_vktx
Name
Prossima data di guadagno
2025-07-23
Name
Ultimi documenti SEC
Name
VKTX's Discussions on Twitter

Confronta VKTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VKTX
Viking Therapeutics Inc
33.50 3.75B 0 -99.15M -74.25M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-04-08 Iniziato Goldman Neutral
2025-02-13 Iniziato Scotiabank Sector Outperform
2025-02-07 Iniziato Citigroup Neutral
2024-12-02 Iniziato Piper Sandler Overweight
2024-11-22 Iniziato B. Riley Securities Buy
2024-11-04 Reiterato H.C. Wainwright Buy
2024-09-11 Iniziato JP Morgan Overweight
2024-06-27 Iniziato Morgan Stanley Overweight
2024-05-16 Aggiornamento Raymond James Outperform → Strong Buy
2024-03-26 Reiterato Oppenheimer Outperform
2024-03-07 Iniziato Jefferies Buy
2024-02-28 Reiterato Oppenheimer Outperform
2023-05-31 Ripresa ROTH MKM Buy
2023-03-28 Reiterato Maxim Group Buy
2023-03-17 Iniziato Stifel Buy
2021-07-29 Ripresa BTIG Research Buy
2021-05-25 Downgrade Raymond James Strong Buy → Outperform
2020-06-05 Iniziato BMO Capital Markets Outperform
2020-05-05 Iniziato Chardan Capital Markets Buy
2020-05-01 Iniziato BTIG Research Buy
2019-07-16 Iniziato Oppenheimer Outperform
2019-06-25 Iniziato Stifel Buy
2019-03-29 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-03-14 Reiterato Maxim Group Buy
2019-02-22 Iniziato SVB Leerink Mkt Perform
2018-12-12 Iniziato B. Riley FBR Buy
2018-11-19 Aggiornamento Raymond James Outperform → Strong Buy
2018-09-18 Reiterato H.C. Wainwright Buy
2018-09-18 Reiterato Maxim Group Buy
2018-09-18 Reiterato Raymond James Outperform
2018-07-20 Iniziato SunTrust Buy
2018-06-28 Iniziato Raymond James Outperform
2018-06-01 Reiterato Laidlaw Buy
2018-05-31 Reiterato Maxim Group Buy
2018-03-26 Ripresa H.C. Wainwright Buy
2017-11-28 Reiterato Maxim Group Buy
2017-11-21 Iniziato ROTH Capital Buy
Mostra tutto

Viking Therapeutics Inc Borsa (VKTX) Ultime notizie

pulisher
Jul 24, 2025

Viking Therapeutics’ Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics EPS miss sends shares down 7% - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Inc. Stock Analysis and ForecastBreakthrough wealth creation - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Q2 Earnings Miss Estimates, R&D Expenses Rise - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - Nasdaq

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics stock rating reiterated by Cantor Fitzgerald at $104 - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - Insider Monkey

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: Navigating Increased R&D ... - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

Is Viking Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Advances Clinical Pipeline Amid Financial Losses - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

Viking Therapeutics' Q2 2025 Earnings Call: Unpacking Key Contradictions in Phase III Study Strategy - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Posts Wider Q2 Loss - AOL.com

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics EPS miss sends shares down 7% (VKTX:NASDAQ) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates - Benzinga

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics, Inc. SEC 10-Q Report - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics shares fall as Q2 loss exceeds estimates By Investing.com - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Viking (VKTX) Q2 2025 Earnings Call Transcript - Mitrade

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | VKTX Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Advances Dual Obesity Drug Strategy: Injectable Phase 3 Trials Begin as Oral Version Nears Data - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Viking Therapeutics Inc. stockSuperior stock selection - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics (VKTX) Options Activity Surges Ahead of Earnings | VKTX Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics to Report Q2 2025 Financial Results on July 23, 2025 - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics, Inc. (NASDAQ:VKTX) institutional owners may be pleased with recent gains after 38% loss over the past year - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025 - Finansavisen

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Viking Therapeutics Inc. stock priceHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Viking Therapeutics (VKTX) Set to Release Q2 Earnings Results - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Better Growth Buy: Eli Lilly vs. Viking Therapeutics - Mitrade

Jul 22, 2025
pulisher
Jul 21, 2025

Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

3 Monster Stocks in the Making to Buy Right Now - The Motley Fool

Jul 21, 2025
pulisher
Jul 20, 2025

Viking Therapeutics VKTX 2025Q2 Earnings Preview Upside Potential Driven by Analyst Price Targets - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Viking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial Results - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

(VKTX) On The My Stocks Page - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 18, 2025

Viking Therapeutics (VKTX) Soars 3.40% on Bullish Analyst Sentiment - AInvest

Jul 18, 2025

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):